GLAXO.BO

GlaxoSmithKline Pharmaceuticals Limited

HealthcareDrug Manufacturers - GeneralININRPeers →Country macro →

$2,332.85

+2.91%Jun 19, 2026

Market cap

$395.05B

52w range

—

P / E

—

EPS · FY 2026

$61.15

Volume

—

Revenue · FY 2026

$38.22B

Explain this page

Arphra AIPlain-English read on GlaxoSmithKline Pharmaceuticals Limited’s valuation

No corporate actions

No dividend or split records loaded for GLAXO-IB.